Galderma Launches Clobex Spray With New Nozzle For Plaque Psoriasis

Clobex is a topical steroid indicated to treat moderate to severe plaque psoriasis in patients 18 years and older. Clobex Spray comes in 2oz and 4.25oz bottles with a non-aerosol, measured-dose spray, and provides clinically proven relief of common symptoms associated with psoriasis.

Galderma Laboratories claimed that the new packaging for Clobex Spray comes with a more targeted nozzle delivery system to help psoriasis patients apply the product more easily and precisely to affected areas of the body and scalp.

Dr Fran Cook-Bolden, director of the Skin Specialty Group and assistant clinical professor of dermatology at Columbia University in New York, said: “Successful treatment of plaque psoriasis with topical steroids hinges upon a patient’s ability to regularly and accurately apply the medication to localized lesions.

“Clobex Spray is already a trusted, easy-to-use treatment option for psoriasis. I think the new nozzle will enhance the patient’s experience with this medication by making the application process simpler and more targeted, and will give patients the Clobex efficacy they’ve come to trust while limiting potential medication overuse.”